RecruitingNCT06828887
About this title
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
Read the official source — NCT06828887Official study titleMulticenter,Randomized,Double-blind,Placebo,Parallel-controlled,Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of Major Depressive Disorder (MDD)
In ShanghaiDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Vigonvita Life Sciences
RecruitingNCT05553353
About this title
Dosing rTMS for Depression Post-SCI
Read the official source — NCT05553353Official study titleEvaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury
In CharlestonDepressionDevice studyAges 18–60
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)